ArticleMolecular cancer research : MCR2022

Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition.

Thabet Alhousami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.